Activation of B-CLL cells by anti CD180 monoclonal antibodies: Responder and non-responder patients.

被引：0
|
作者：
Porakishvili, N
Slovick, A
Jewell, AP
Youinou, PY
Nathwani, A
Yong, K
Stevenson, F
Clark, EA
Lydyard, PM
机构：
[1] Univ Westminster, Sch Biosci, London, England
[2] Royal Free & UCL Med Sch, London, England
[3] Kingston Univ, Sch Life Sci, Kingston upon Thames KT1 2EE, Surrey, England
[4] Brest Univ, Brest, France
[5] Univ Southampton, Tenovus Res Labs, Southampton SO9 5NH, Hants, England
[6] Univ Washington, Seattle, WA 98195 USA
来源：
BLOOD | 2003年 / 102卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1571
引用
收藏
页码：432A / 432A
页数：1
相关论文
共 50 条
  • [21] DCE-MRI DISCRIMINATES BETWEEN RESPONDER AND NON-RESPONDER IN RECURRENT HIGH-GRADE GLIOMA PATIENTS UNDERGOING ANTI-ANGIOGENIC TREATMENT
    Nowosielski, M.
    Kremser, C.
    Schocke, M.
    Gizewski, E.
    Iglseder, S.
    Muigg, A.
    Freyschlag, C.
    Stockhammer, G.
    Hutterer, M.
    NEURO-ONCOLOGY, 2014, 16
  • [22] HIGH SENSITIVE METHODS TO IDENTIFY K-RAS MUTATIONS INCREASE THE DETECTION OF NON-RESPONDER METASTATIC COLORECTAL CANCER PATIENTS TREATED WITH ANTI-EGFR MONOCLONAL ANTIBODIES
    Molinari, F. M.
    Felicioni, L. F.
    Buscarino, M. B.
    De Dosso, S. D.
    Buttitta, F. B.
    Malatesta, S. M.
    Di Nicolantonio, F. D.
    Saletti, P. S.
    Mazzucchelli, L. M.
    Marchetti, A. M.
    Bardelli, A. B.
    Frattini, M. F.
    ANNALS OF ONCOLOGY, 2010, 21 : I33 - I34
  • [23] CROSSREACTION OF MONOCLONAL-ANTIBODIES DIRECTED AGAINST T-CELLS WITH CELLS OF B-CLL
    MUNKER, R
    THIEL, E
    KUMMER, U
    THIERFELDER, S
    IMMUNOLOGICAL COMMUNICATIONS, 1983, 12 (01): : 62 - 62
  • [24] Apoptotic effect of dexamethasone and cyclosporin A in malignant cells of B-CLL patients.
    Cabrelle, A
    Trentin, L
    Dal Zilio, B
    Maschio, N
    Baesso, I
    Facco, M
    Trevisan, T
    Binotto, G
    Agostini, C
    Zambello, R
    Semenzato, G
    BLOOD, 2002, 100 (11) : 354B - 354B
  • [25] Low dose ribavirin (RBV) in combination interferon (IFN) for the treatment of hepatitis C non-responder and relapse patients.
    Bernstein, DE
    Khan, R
    Jeffers, LJ
    Reddy, KR
    Schiff, ER
    HEPATOLOGY, 1998, 28 (04) : 702A - 702A
  • [26] Amantadine triple therapy for non-responder hepatitis C patients.: Clues for controversies (ANRS HC 03 BITRI)
    Maynard, M
    Pradat, P
    Bailly, F
    Rozier, F
    Nemoz, C
    Ahmed, SNS
    Adeleine, P
    Trépo, C
    JOURNAL OF HEPATOLOGY, 2006, 44 (03) : 484 - 490
  • [27] CD180 functions in activation, survival and cycling of B chronic lymphocytic leukaemia cells
    Porakishvili, Nino
    Memon, Azka
    Vispute, Ketki
    Kulikova, Nina
    Clark, Edward A.
    Rai, Kanti R.
    Nathwani, Amit
    Damle, Rajendra N.
    Chiorazzi, Nicholas
    Lydyard, Peter M.
    BRITISH JOURNAL OF HAEMATOLOGY, 2011, 153 (04) : 486 - 498
  • [28] UNUSUAL PHENOTYPE OF CIRCULATING IMMUNOREGULATORY T-CELLS IN PATIENTS WITH B-CLL AS DEFINED BY MONOCLONAL-ANTIBODIES
    HERRMANN, F
    LOCHNER, A
    LUDWIG, WD
    ENDERS, B
    SIEBER, G
    RUHL, H
    IMMUNOBIOLOGY, 1982, 162 (4-5) : 363 - 363
  • [29] Anti-factor VIII antibodies that neutralize FVIII procoagulant activity, are present in plasma of non-responder patients with severe hemophilia A and in normal human IgG
    Kaveri, SV
    Moreau, A
    Lacroix-Desmazes, S
    Stieltjes, N
    Saenko, E
    Scandella, D
    Kazatchkine, MD
    FASEB JOURNAL, 2000, 14 (06): : A1106 - A1106
  • [30] Gene expression/qRT-PCR analysis in psoriatic disease: Translational approaches to identify responder from non-responder psoriasis patients treated with Anti-TNFα biologics
    Francis, S. O.
    Fujita, M.
    Dellavalle, R.
    Norris, D. A.
    Edwards, C. K.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2009, 129 : S88 - S88
12345